Assessment in time Interview/history-taking Related PT goals Emerging problems during PT‡ 0 weeks A-specific low back pain, VAS = 7/10 Walking < 5 min Reduce pain, VAS < 7 Sit and walk > 30 min Non-reported dyspneaoverlooked; not all comorbidities and medication known to PT 8 weeks A-specific low back pain, VAS = 1/10 Walking ≤ 6 min Dyspnea, MRC = 4/5   8 weeks* COPD GOLD IV ­FEV1/FVC = 0.41 ­FEV1 = 46% of predicted, chronic respiratory failure ­Resting SpO2 = 95% ­Dyspnea, MRC = 4/5 ­Walking ≤ 6 min ­Nicotine addiction, 67.5 pack years ­Physical activity, daily walking 15 min Depression Hypotension, 79/53 mmHg, resting heart rate = 57 beats/min Medication: ­Oral corticosteroids ­Bronchodilators ­Long term oxygen therapy (2.0 l/min ­Anti-depressive drug ­Vitamin pill ­Stomach protective drug Reduce dyspnea, MRC < 4 Improve exercise capacity & physical activity in daily life, walk > 30 min Patient information as source for comorbidity and medication is not sufficient à information from referring physician and pharmacy needed! 9 weeks† Exercise SpO2 = 78% Decompensated heart failure: stomach protective drug = beta-adrenergic blocker!   Patient information on medication not checked by PT à pharmacy records or drug packing material *Reassessment at 8 weeks due to unattained goals (walk ≤ 6 min); †Serious adverse event during exercise happened at 9 weeks; ‡ Emerging problems during PT due to failures in the communication and the clinical decision-making process. PT: Physical Therapist; VAS: Visual Analogue Scale; min: minute; MRC: Medical Research Council Dyspnea scale; COPD: Chronic Obstructive Pulmonary Disease; GOLD IV: very severe COPD; FEV1/FVC: Forced Expiratory Ratio; FEV1: % Forced Expiratory Volume in one second of predicted; SpO2: Transcutaneous Oxygen saturation

Table 1: Collected data and assessment data of case 1.

Goto home»